Two Sigma Investments, LP Jazz Pharmaceuticals PLC Call Options Transaction History

Two Sigma Investments, LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$129.64 - $160.7 $933,407 - $1.16 Million	-7,200 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $2.72 Million - $3.31 Million	-22,700 Reduced 75.92%	7,200 $917,000
Q3 2021 Nov 15, 2021	BUY	$128.64 - $184.79 $3.85 Million - $5.53 Million	29,900 New	29,900 $3.89 Million
Q1 2020 May 15, 2020	SELL	$87.74 - $152.74 $166,706 - $290,206	-1,900 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$117.65 - $153.73 $129,415 - $169,103	-1,100 Reduced 36.67%	1,900 $284,000
Q3 2019 Nov 14, 2019	SELL	$125.18 - $143.24 $525,756 - $601,608	-4,200 Reduced 58.33%	3,000 $384,000
Q3 2017 Nov 14, 2017	BUY	$142.62 - $155.6 $1.03 Million - $1.12 Million	7,200	7,200 $1.05 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.6B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.